Mirae Asset Global ETFs Holdings’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$6.06K Buy
2024
Q4
$9.66K Buy
2024
Q3
$15.1K Sell
2024
Q2
$31K Buy